VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

He, HX; Gao, Y; Fu, JC; Zhou, QH; Wang, XX; Bai, B; Li, PF; Huang, C; Rong, QX; Ping, LQ; He, YX; Mao, JY; Chen, X; Huang, HQ

Zhou, QH (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol, South China & Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.; Chen, X (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China.

ONCOIMMUNOLOGY, 2021; 10 (1):

Abstract

Although PD-1/PD-L1 blockade therapy confers salutary effects across cancer types, their efficacy in Extranodal Natural killer/T-cell lymphoma (ENKTCL......

Full Text Link